Baxalta
1 follower
‌
Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing.
Industries
Headquarters
Employees
Links
Org chart
Christophe Weber
President, CEO & Representative Director
Christophe Weber
Collapse
Costa Saroukos
CFO & Director
Lauren Duprey
CHRO
Takako Ohyabu
Chief Global Corporate Affairs & Sustainability Officer
Mwana Lugogo
Chief Ethics & Compliance Officer
Gabriele Ricci
Chief Data & Technology Officer
Teresa Bitetti
President, Global Oncology Business Unit
Andrew S. Plump
Director & President, Research & Development
Milano Furuta
President, Japan Pharma Business Unit
Giles Platford
President, Plasma-Derived Therapies Business Unit
Ramona Sequeira
President, Global Portfolio Division
Marcello Agosti
Global Business Development Officer
Yoshihiro Nakagawa
Global General Counsel
Koki Sato
Corporate Strategy Officer & Chief of Staff
Thomas Wozniewski
Global Manufacturing & Supply Officer
Allen Harmon
Head Of Quality
Francisco Samir Serralde
Head Of Sales Mexico
Judith Murphy
Sr. Director, External Partnerships
Malin Gillgren Aspehult
Head Of Marketing, Immunology Nordic
